• Home
  • Print
  • About GeNeuro
  • Technologies
  • Investors and Partnering
  • News & Press
  • Patients
  • Careers
  • Contact
  • Recent scientific publications
  • Key scientific Publications
  • Press Articles

News

Peripheral Nerve Society - Saint Malo - 29th June to 3rd July 2013

GeNeuro will present two posters.

Peripheral Nerve Society


European College of Neuropsychopharmacology - Barcelona - 5th to 9th October 2013

GeNeuro will do an oral presentation as invited speaker.

European College of Neuropsychopharmacology

 

 


18 September 2012, Plan-les-Ouates, Geneva, Switzerland - GeNeuro SA announces the launch of a phase IIa clinical study with GNbAC1, a humanized monoclonal antibody targeting a human endogenous retrovirus, to treat multiple sclerosis.

The randomized placebo-controlled phase IIa study will test single ascending doses of GNbAC1 in patients with multiple sclerosis for the first time.  


 

18, chemin des Aulx, CH-1228 Plan-les-Ouates - Geneva, Switzerland | Tel: +41 22 794 50 85 | E-mail : contact@geneuro.com
© 2011 GeNeuro SA